How to Get Jakafi (Ruxolitinib) Covered by UnitedHealthcare in Pennsylvania: Complete Appeals Guide
Quick Answer: Getting Jakafi Covered by UnitedHealthcare in Pennsylvania
UnitedHealthcare requires prior authorization for Jakafi (ruxolitinib) in Pennsylvania. For myelofibrosis, you need intermediate/high-risk disease documentation. For polycythemia vera, you must document hydroxyurea failure after ≥14 days at maximum tolerated dose. Submit PA requests via the UHC Provider Portal or